Multiple receptor tyrosine kinase activation attenuates therapeutic efficacy of the fibroblast growth factor receptor 2 inhibitor AZD4547 in <i>FGFR2</i> amplified gastric cancerJinjia Chang, Jin Li|Oncotarget|2014Cited by 49